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acute Viral Myopericarditis presenting as a transient    
Effusive-Constrictive Pericarditis Caused by Coinfection with 
coxsackieviruses a4 and B3
Wang-Soo Lee, Kwang Je Lee, Jee Eun Kwon, Min Seok Oh, Jeong Eun Kim, Eun Jung Cho, and  
Chee Jeong Kim
Division of Cardiology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, 
Korea
Acute myopericarditis is usually caused by viral infections, and the most common cause of viral myopericarditis 
is coxsackieviruses. Diagnosis of myopericarditis is made based on clinical manifestations of myocardial (such as 
myocardial dysfunction and elevated serum cardiac enzyme levels) and pericardial (such as inflammatory pericardial 
effusion) involvement. Although endomyocardial biopsy is the gold standard for the confirmation of viral infection, 
serologic tests can be helpful. Conservative management is the mainstay of treatment in acute myopericarditis. We 
report here a case of a 24-year-old man with acute myopericarditis who presented with transient effusive-constrictive 
pericarditis. Echocardiography showed transient pericardial effusion with constrictive physiology and global regional 
wall motion abnormalities of the left ventricle. The patient also had an elevated serum troponin I level. A computed 
tomogram of the chest showed pericardial and pleural effusion, which resolved after 2 weeks of supportive treatment. 
Serologic testing revealed coxsackievirus A4 and B3 coinfection. The patient received conservative medical treatment, 
including nonsteroidal anti-inflammatory drugs, and he recovered completely with no complications.
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IntRoDuCtIon
Acute myocarditis is an acute inflammatory disor-
der that primarily involves the myocardium. It can be 
caused by various drugs, systemic diseases, toxins, and 
infections, although viral infection is the most common 
etiology [1]. Acute pericarditis is often accompanied by 
some degree of myocarditis, although these two entities 
are not always associated. In clinical practice, pericar-
ditis and myocarditis coexist because they share com-
mon etiologic agents, mainly cardiotropic viruses such 
as coxsackieviruses [2,3]. Effusive-constrictive pericar-
ditis is a clinical hemodynamic syndrome in which con-
striction of the heart by the visceral pericardium occurs 
in the presence of tense effusion in a free pericardial 
space [4].
Diagnosing and managing acute myopericarditis at 
an early stage is important, but difficult, since it mim-
ics acute myocardial infarction and its natural course is 
markedly heterogeneous, ranging from self-limiting to Lee WS, et al. Acute viral myopericarditis with transient effusive-constriction   217
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cardiopulmonary collapse or death. Few reports have 
described acute myopericarditis presenting as transient 
effusive-constrictive pericarditis and mimicking acute 
myocardial infarction. Thus, we report here a case of 
acute viral myopericarditis presenting as transient effu-
sive-constrictive pericarditis and caused by coinfection 
with coxsackieviruses A4 and B3.
CAse RepoRt
A 24-year-old man presented to the emergency de-
partment with chest pain, nausea, shortness of breath, 
and general weakness. The patient mentioned having 
flu-like symptoms 2 weeks prior to presentation. He had 
no significant past medical history or family history. 
He had a heart rate of 150 beats/min, blood pressure of 
85/60 mmHg, respiratory rate of 22 breaths/min, and 
body temperature of 36.4°C. 
Figure 1. Initial electrocardiogram (ECG) showing ST segment elevation in the V2-V6 leads (A). Two weeks later, ECG had normalized (B).
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Initial laboratory findings revealed a white blood cell 
count of 14,530/mm
3, a hemoglobin level of 16.3 g/dL, 
and a platelet count of 168,000/mm
3. Cardiac enzyme 
findings were as follows: creatinine kinase (CK) 256 IU/
L (reference range, 0 to 190), CK-MB 16.32 ng/mL (ref-
erence range, 0 to 5), and troponin I 10.16 ng/mL (refer-
ence range, 0 to 0.78). The B-type natriuretic peptide 
level was elevated at 190.48 pg/mL (reference range, 2 
to 100). The initial electrocardiogram showed ST seg-
ment elevation in V2-V6 (Fig. 1A). Echocardiography 
showed global wall motion abnormalities and moderate 
systolic dysfunction (EF, 38%) in the left ventricle (LV), 
with a moderate amount of pericardial effusion (Fig. 
2A). Echocardiography revealed constrictive physiology, 
such as septal bouncing, significant respiratory varia-
tion in the mitral inflow E wave (Fig. 2C), and increased 
diastolic flow reversal in the hepatic vein on expiration 
(Fig. 2D). Initial chest X-ray and chest computed to-
mography (CT) showed pericardial and bilateral pleural 
effusions (Fig. 3A). Ultrasound-guided aspiration of the 
pleural effusion revealed a transudate. Coronary angi-
ography was normal. Tests for Epstein-Barr virus IgM, 
Figure 2. Initial echocardiogram showing moderate pericardial effusion (A), abnormal septal motion and systolic dysfunction of the left 
ventricle (B), respiratory variation of the mitral inflow E wave (C), increased diastolic flow reversal with expiration in the hepatic vein (D), 
and plethora of the inferior vena cava (E). Tissue Doppler imaging of the septal mitral annulus indicated normal diastolic function (F).
Figure 3. Chest computed tomography (CT) showing pericardial and bilateral pleural effusions (A). Follow-up CT after 4 weeks 
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cytomegalovirus IgM, herpes simplex virus IgM, anti-
neutrophil cytoplasmic antibodies, antinuclear antibod-
ies, and anti-dsDNA were all negative. However, en-
zyme-linked immunosorbent assay serologic antibody 
tests for coxsackievirus revealed a high serum titer (> 
1:32) of serotypes A4 and B3.
The patient received conservative treatment with 
ibuprofen, ramipril, and furosemide, and his cardiac 
enzymes and ST segment elevation normalized within 
2 weeks (Fig. 1B). After 4 weeks, chest CT indicated dis-
appearance of the pericardial and pleural effusions (Fig. 
3B). Echocardiography showed disappearance of con-
strictive physiology and normalized LV systolic function 
without regional wall motion abnormalities (Fig. 4). 
Follow-up coxsackievirus A4 and B3 antibody titers had 
normalized after 6 months.
DIsCussIon
This case illustrates acute myopericarditis with 
transient effusive-constrictive pericarditis caused by 
coinfection with coxsackieviruses A4 and B3. When 
considering acute myocarditis and acute pericarditis, 
physicians usually place clinical emphasis on one or the 
other diagnosis. However, acute myopericarditis must 
be distinguished from pericarditis since a diagnosis of 
myocarditis has greater prognostic significance than 
that of pericarditis. Myocarditis can lead to fatal com-
plications, including ventricular arrhythmia, or cardiac 
dilatation and subsequent cardiac collapse. These com-
plications can develop abruptly and rapidly become life-
threatening [1,5].
Endomyocardial biopsy is not always required, as it 
is associated with certain procedural risks and offers 
limited benefits from a therapeutic perspective. Nev-
ertheless, it remains the gold standard for diagnosing 
myocarditis [2]. We did not perform an invasive endo-
myocardial biopsy on our patient since he responded 
well to medical treatment. The limited sensitivity and 
specificity of this diagnostic test demonstrate that the 
accurate diagnosis of myocarditis should not be based 
on histopathologic findings alone.
Effusive-constrictive pericarditis is an uncommon 
clinical entity characterized by pericardial effusion 
with constrictive physiology. It is regarded as a form of 
subacute constrictive pericarditis. The effusion may be 
lobulated, concentric, or regional. Over time, the effu-
sion may become organized and the pericardial layers 
may become thickened [6].
In some patients with acute constrictive pericarditis, 
however, the symptoms and constrictive physiologic 
features resolve with medical management alone, a 
phenomenon that was first reported in 1987 and has 
been designated transient constrictive pericarditis [7]; 
this occurs frequently in post-pericardiectomy patients. 
However, it is also seen postinfection or in the setting of 
uremia. A recent study of 212 patients who had echocar-
diographic findings of constrictive pericarditis showed 
that 17% of these patients had resolution of constric-
tive physiology on follow-up echocardiography, without 
the need for pericardiectomy. In a subset of 22 patients 
who were followed regularly during the course of their 
illness, resolution of the constrictive hemodynamic fea-
tures occurred an average of 8.3 weeks after diagnosis 
[8]. In the present case, 4 weeks was required for tran-
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Figure 4. A follow-up echocardiogram revealed normalized septal motion and left ventricular systolic function (A), disappeared 
pericardial effusion, and normal respiratory variation of the mitral inflow E wave (B) and inferior vena cava (C).220    The Korean journal of Internal Medicine Vol. 27, No. 2, june 2012
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sient constrictive hemodynamics to resolve based on 
echocardiographic follow-up studies. 
Respiratory variations in the mitral inflow and cen-
tral venous flow velocities can be diagnostic, even in 
patients without definite pericardial abnormalities [9]. 
Tissue Doppler imaging (TDI) is a relatively new and 
effective echocardiographic tool that can help in the 
clinical diagnosis of constrictive pericarditis. Incremen-
tal M-mode, 2D, and transmitral flow Doppler studies 
with TDI provide an overall sensitivity and specificity of 
88.8% and 94.8%, respectively, for the diagnosis of con-
strictive pericarditis [10].
Pericardiectomy is the gold standard for the treatment 
of recurrent or constrictive pericarditis [3]. However, in 
some patients, such as our own, constrictive pericarditis 
may resolve spontaneously or after treatment with anti-
inflammatory agents such as those mentioned above. 
Our patient recovered without sequelae.
In conclusion, acute myopericarditis must be distin-
guished from acute pericarditis because of the possibil-
ity of rapid, life-threatening progression. Thus, early 
diagnosis and management are important. With that in 
mind, clinical examination and echocardiography are 
essential. If a patient presenting with acute viral myo-
pericarditis has signs of transient effusive-constrictive 
pericarditis, then he or she can be treated with medical 
therapy and followed with serial echocardiographic ex-
aminations.
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